Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.40 |
| ▸ | MAOA | P21397 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.34 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 2/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30630035 | 0.83 | MAOA (0.34) | MAOBMAOA | |
| SCHEMBL30009763 | 0.83 | RIPK1 (0.36) | MAOBMAOAALDH1A1 | |
| Hydrochloric Acid SCHEMBL31478169 | 0.82 | RIPK1 (0.35) | MAOBMAOAALDH1A1 | |
| SCHEMBL4486104 | 0.80 | HTR6 (0.33) | — | |
| SCHEMBL1843873 | 0.80 | MAOB (0.39) | MAOBMAOAALDH1A1PPARGNCOA2 | |
| SCHEMBL30591327 | 0.71 | MAOA (0.35) | MAOBMAOAALDH1A1 | |
| SCHEMBL10287802 | 0.69 | ALDH1A1 (0.38) | MAOBMAOAALDH1A1 | |
| SCHEMBL14275214 | 0.68 | MAPT (0.34) | ALDH1A1 | |
| SCHEMBL1843874 | 0.68 | MAOB (0.41) | MAOBMAOAALDH1A1PPARGNCOA2 | |
| SCHEMBL30591330 | 0.65 | SLC18A3 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263367-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2025-08-21 | — | — | US | disclosed |
| EP-4341246-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-2022245627-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263367-A1 | A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES | TAS2R40, TAS2R10, TAS2R9 | MAOB 3725/4885MAOA 4094/4885ALDH1A1 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.